Delayed pressure urticaria - Dapsone heading for first-line therapy?

Summary Background: Pressure urticaria as a subform of physical urticaria is rare and treatment is often difficult. Established therapeutic regimes include antihistamines (generally exceeding approved dosages in order to achieve a therapeutic benefit) or antihistamines combined with montelukast. Com...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal der Deutschen Dermatologischen Gesellschaft 2011-11, Vol.9 (11), p.908-912
Hauptverfasser:	Grundmann, Sonja Alexandra, Kiefer, Sabine, Luger, Thomas Anton, Brehler, Randolf
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Anti-Infective Agents - adverse effects Anti-Infective Agents - therapeutic use Ascorbic Acid - administration & dosage Chronic Disease chronic urticaria dapsone Dapsone - adverse effects Dapsone - therapeutic use Dose-Response Relationship, Drug Drug Administration Schedule Drug Resistance drug therapy Drug Therapy, Combination Female Humans Male Methemoglobin - metabolism Middle Aged Pressure - adverse effects pressure urticaria Retrospective Studies urticaria Urticaria - blood Urticaria - drug therapy Urticaria - etiology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!